NYSE$CI
Cigna Group · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Cigna reported strong fourth quarter and full year 2021 results, expecting continued revenue and attractive earnings per share growth in 2022.
Cigna Corporation reported strong business growth in 2021, aided by a diversified portfolio. The company is focusing on making healthcare more affordable, predictable, and simple in 2022.
- Total revenues for 2021 were $174.1 billion.
- Shareholders’ net income for 2021 was $5.4 billion, or $15.73 per share.
- Cigna's adjusted income from operations for 2021 was $7.0 billion, or $20.47 per share.
- Cigna's outlook for full year 2022 adjusted revenues is projected to be at least $177 billion.
Headline financials
Revenue & EPS history
Cigna · Revenue · Quarterly
$45.7B
Forward guidance
Cigna's outlook for full year 2022 adjusted revenues is projected to be at least $177 billion. Cigna’s outlook for full year 2022 consolidated adjusted income from operations is projected to be at least $6.95 billion, or at least $22.40 per share.
Tailwinds
- Projected adjusted revenue outlook for 2022 is at least $177 billion.
- Projected adjusted income from operations is at least $6.95 billion.
- The outlook includes the impact of expected future share repurchases.
- The outlook includes anticipated 2022 dividends.
- The outlook assumes that the divestiture of international life, accident, and supplemental benefits businesses will close in the second quarter of 2022.
Headwinds
- Actual results may differ materially depending on a number of factors.
- The scale, scope and duration of the COVID-19 pandemic and its potential impact on our business, operating results, cash flows or financial condition
- Our ability to compete effectively, differentiate our products and services from those of our competitors and maintain or increase market share
- Price competition and other pressures that could compress our margins or result in premiums that are insufficient to cover the cost of services delivered to our customers
- The potential for actual claims to exceed our estimates related to expected medical claims
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
-0.9%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-0.4%
Avg return
30 days after
48%
31 / 65 earnings
Positive
+8.6%
Q1 2023
Best reaction
-17.4%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.5% | -5.7% | -5.2% | |
| Q4 2025 | -0.6% | -5.7% | -5.2% | |
| Q3 2025 | -17.4% | -11.5% | -7.3% | |
| Q2 2025 | -10.2% | -9.1% | +1.0% | |
| Q1 2025 | -0.5% | -0.2% | -5.5% | |
| Q4 2024 | -6.7% | -3.9% | +1.8% | |
| Q3 2024 | +1.2% | +1.8% | +8.0% | |
| Q2 2024 | -3.3% | -5.6% | +3.8% | |
| Q1 2024 | -4.4% | -2.9% | -3.5% | |
| Q4 2023 | +4.5% | +7.6% | +8.3% | |
| Q3 2023 | +0.4% | -4.6% | -13.1% | |
| Q2 2023 | -4.3% | -2.4% | -7.6% | |
| Q1 2023 | +8.6% | +8.1% | +5.5% | |
| Q4 2022 | -4.3% | -3.8% | -4.8% | |
| Q3 2022 | +0.4% | +2.1% | +2.0% | |
| Q2 2022 | +3.7% | +4.9% | +5.9% | |
| Q1 2022 | +4.4% | +1.9% | -0.7% | |
| Q4 2021 | -3.8% | +0.8% | +5.0% | |
| Q3 2021 | -1.9% | -0.9% | -8.4% | |
| Q2 2021 | -9.6% | -8.9% | -6.3% | |
| Q1 2021 | +3.9% | +0.7% | -1.6% | |
| Q4 2020 | -7.3% | -3.8% | +5.1% | |
| Q3 2020 | -4.3% | +4.5% | +3.3% | |
| Q2 2020 | -5.0% | -4.6% | -0.4% | |
| Q1 2020 | -4.5% | -2.8% | +0.7% | |
| Q4 2019 | +1.2% | +4.2% | -5.3% | |
| Q3 2019 | +1.7% | +3.1% | +13.3% | |
| Q2 2019 | -3.1% | -3.6% | -9.4% | |
| Q1 2019 | -5.7% | -4.2% | -8.6% | |
| Q4 2018 | -3.9% | -6.2% | -10.8% | |
| Q3 2018 | -0.3% | +0.2% | +4.5% | |
| Q2 2018 | +3.5% | +2.9% | +3.0% | |
| Q1 2018 | -0.7% | -1.0% | -0.9% | |
| Q4 2017 | -1.9% | -5.2% | -7.3% | |
| Q3 2017 | +2.1% | +3.9% | +5.3% | |
| Q2 2017 | -0.0% | +1.2% | +4.0% | |
| Q1 2017 | +3.2% | +3.9% | +4.9% | |
| Q4 2016 | +1.1% | +0.2% | +2.9% | |
| Q3 2016 | +3.2% | +9.3% | +13.2% | |
| Q2 2016 | -6.8% | -8.4% | -6.1% | |
| Q1 2016 | -2.6% | — | — | |
| Q4 2015 | +0.4% | — | — | |
| Q3 2015 | +0.4% | — | — | |
| Q2 2015 | -0.9% | — | — | |
| Q1 2015 | -0.9% | — | — | |
| Q4 2014 | +1.5% | — | — | |
| Q3 2014 | +5.9% | — | — | |
| Q2 2014 | -2.9% | — | — | |
| Q1 2014 | +3.3% | — | — | |
| Q4 2013 | -10.1% | — | — | |
| Q3 2013 | +5.0% | — | — | |
| Q2 2013 | -0.7% | — | — | |
| Q1 2013 | +2.7% | — | — | |
| Q4 2012 | +3.8% | — | — | |
| Q3 2012 | +4.1% | — | — | |
| Q2 2012 | +4.6% | — | — | |
| Q1 2012 | -2.8% | — | — | |
| Q4 2011 | +2.9% | — | — | |
| Q3 2011 | -6.0% | — | — | |
| Q2 2011 | +1.8% | — | — | |
| Q1 2011 | +2.4% | — | — | |
| Q4 2010 | +4.3% | — | — | |
| Q3 2010 | +2.0% | — | — | |
| Q2 2010 | -6.3% | — | — | |
| Q1 2010 | +1.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro